梅斯医学

订阅

MedSci主页 / 所有栏目 / 梅斯医学

肺栓塞病人是不是EBUS-TBNA的禁忌症？低分子肝素抗凝期间需要TBNA时，低分子肝素什么时候停药以及注意事项有哪些？

2021-11-03 MedSci原创 MedSci原创

呼吸科支气管镜下
关注

支气管镜下诊疗技术临床应用问题-2

评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1930277, encodeId=028319302e78a, content=<a href='/topic/show?id=0aac64623a' target=_blank style='color:#2F92EE;'>#EBUS-TBNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6462, encryptionId=0aac64623a, topicName=EBUS-TBNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Sep 11 15:06:45 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906772, encodeId=40531906e72cc, content=<a href='/topic/show?id=6440650062f' target=_blank style='color:#2F92EE;'>#注意事项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65006, encryptionId=6440650062f, topicName=注意事项)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6ac207, createdName=xlwang2691, createdTime=Thu Nov 04 05:06:45 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460860, encodeId=8790146086046, content=<a href='/topic/show?id=b8012e675d7' target=_blank style='color:#2F92EE;'>#停药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27675, encryptionId=b8012e675d7, topicName=停药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c6d6379100, createdName=yinhl1980, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466747, encodeId=9b931466e471e, content=<a href='/topic/show?id=67f3e463637' target=_blank style='color:#2F92EE;'>#禁忌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74636, encryptionId=67f3e463637, topicName=禁忌症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06006859456, createdName=xlxchina, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481464, encodeId=e07d1481464c0, content=<a href='/topic/show?id=cf432615e79' target=_blank style='color:#2F92EE;'>#低分子肝素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26157, encryptionId=cf432615e79, topicName=低分子肝素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=192e7793966, createdName=jingyanzhu715_39486103, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545124, encodeId=7b30154512471, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066636, encodeId=471510666361f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edc65641393, createdName=ms9000001434185440, createdTime=Wed Nov 03 16:45:45 CST 2021, time=2021-11-03, status=1, ipAttribution=)]
    2022-09-11 cy0324

    #EBUS-TBNA#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1930277, encodeId=028319302e78a, content=<a href='/topic/show?id=0aac64623a' target=_blank style='color:#2F92EE;'>#EBUS-TBNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6462, encryptionId=0aac64623a, topicName=EBUS-TBNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Sep 11 15:06:45 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906772, encodeId=40531906e72cc, content=<a href='/topic/show?id=6440650062f' target=_blank style='color:#2F92EE;'>#注意事项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65006, encryptionId=6440650062f, topicName=注意事项)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6ac207, createdName=xlwang2691, createdTime=Thu Nov 04 05:06:45 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460860, encodeId=8790146086046, content=<a href='/topic/show?id=b8012e675d7' target=_blank style='color:#2F92EE;'>#停药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27675, encryptionId=b8012e675d7, topicName=停药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c6d6379100, createdName=yinhl1980, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466747, encodeId=9b931466e471e, content=<a href='/topic/show?id=67f3e463637' target=_blank style='color:#2F92EE;'>#禁忌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74636, encryptionId=67f3e463637, topicName=禁忌症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06006859456, createdName=xlxchina, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481464, encodeId=e07d1481464c0, content=<a href='/topic/show?id=cf432615e79' target=_blank style='color:#2F92EE;'>#低分子肝素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26157, encryptionId=cf432615e79, topicName=低分子肝素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=192e7793966, createdName=jingyanzhu715_39486103, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545124, encodeId=7b30154512471, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066636, encodeId=471510666361f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edc65641393, createdName=ms9000001434185440, createdTime=Wed Nov 03 16:45:45 CST 2021, time=2021-11-03, status=1, ipAttribution=)]
    2021-11-04 xlwang2691

    #注意事项#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1930277, encodeId=028319302e78a, content=<a href='/topic/show?id=0aac64623a' target=_blank style='color:#2F92EE;'>#EBUS-TBNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6462, encryptionId=0aac64623a, topicName=EBUS-TBNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Sep 11 15:06:45 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906772, encodeId=40531906e72cc, content=<a href='/topic/show?id=6440650062f' target=_blank style='color:#2F92EE;'>#注意事项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65006, encryptionId=6440650062f, topicName=注意事项)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6ac207, createdName=xlwang2691, createdTime=Thu Nov 04 05:06:45 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460860, encodeId=8790146086046, content=<a href='/topic/show?id=b8012e675d7' target=_blank style='color:#2F92EE;'>#停药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27675, encryptionId=b8012e675d7, topicName=停药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c6d6379100, createdName=yinhl1980, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466747, encodeId=9b931466e471e, content=<a href='/topic/show?id=67f3e463637' target=_blank style='color:#2F92EE;'>#禁忌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74636, encryptionId=67f3e463637, topicName=禁忌症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06006859456, createdName=xlxchina, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481464, encodeId=e07d1481464c0, content=<a href='/topic/show?id=cf432615e79' target=_blank style='color:#2F92EE;'>#低分子肝素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26157, encryptionId=cf432615e79, topicName=低分子肝素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=192e7793966, createdName=jingyanzhu715_39486103, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545124, encodeId=7b30154512471, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066636, encodeId=471510666361f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edc65641393, createdName=ms9000001434185440, createdTime=Wed Nov 03 16:45:45 CST 2021, time=2021-11-03, status=1, ipAttribution=)]
    2021-11-05 yinhl1980

    #停药#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1930277, encodeId=028319302e78a, content=<a href='/topic/show?id=0aac64623a' target=_blank style='color:#2F92EE;'>#EBUS-TBNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6462, encryptionId=0aac64623a, topicName=EBUS-TBNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Sep 11 15:06:45 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906772, encodeId=40531906e72cc, content=<a href='/topic/show?id=6440650062f' target=_blank style='color:#2F92EE;'>#注意事项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65006, encryptionId=6440650062f, topicName=注意事项)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6ac207, createdName=xlwang2691, createdTime=Thu Nov 04 05:06:45 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460860, encodeId=8790146086046, content=<a href='/topic/show?id=b8012e675d7' target=_blank style='color:#2F92EE;'>#停药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27675, encryptionId=b8012e675d7, topicName=停药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c6d6379100, createdName=yinhl1980, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466747, encodeId=9b931466e471e, content=<a href='/topic/show?id=67f3e463637' target=_blank style='color:#2F92EE;'>#禁忌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74636, encryptionId=67f3e463637, topicName=禁忌症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06006859456, createdName=xlxchina, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481464, encodeId=e07d1481464c0, content=<a href='/topic/show?id=cf432615e79' target=_blank style='color:#2F92EE;'>#低分子肝素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26157, encryptionId=cf432615e79, topicName=低分子肝素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=192e7793966, createdName=jingyanzhu715_39486103, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545124, encodeId=7b30154512471, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066636, encodeId=471510666361f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edc65641393, createdName=ms9000001434185440, createdTime=Wed Nov 03 16:45:45 CST 2021, time=2021-11-03, status=1, ipAttribution=)]
    2021-11-05 xlxchina

    #禁忌症#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1930277, encodeId=028319302e78a, content=<a href='/topic/show?id=0aac64623a' target=_blank style='color:#2F92EE;'>#EBUS-TBNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6462, encryptionId=0aac64623a, topicName=EBUS-TBNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Sep 11 15:06:45 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906772, encodeId=40531906e72cc, content=<a href='/topic/show?id=6440650062f' target=_blank style='color:#2F92EE;'>#注意事项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65006, encryptionId=6440650062f, topicName=注意事项)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6ac207, createdName=xlwang2691, createdTime=Thu Nov 04 05:06:45 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460860, encodeId=8790146086046, content=<a href='/topic/show?id=b8012e675d7' target=_blank style='color:#2F92EE;'>#停药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27675, encryptionId=b8012e675d7, topicName=停药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c6d6379100, createdName=yinhl1980, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466747, encodeId=9b931466e471e, content=<a href='/topic/show?id=67f3e463637' target=_blank style='color:#2F92EE;'>#禁忌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74636, encryptionId=67f3e463637, topicName=禁忌症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06006859456, createdName=xlxchina, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481464, encodeId=e07d1481464c0, content=<a href='/topic/show?id=cf432615e79' target=_blank style='color:#2F92EE;'>#低分子肝素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26157, encryptionId=cf432615e79, topicName=低分子肝素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=192e7793966, createdName=jingyanzhu715_39486103, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545124, encodeId=7b30154512471, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066636, encodeId=471510666361f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edc65641393, createdName=ms9000001434185440, createdTime=Wed Nov 03 16:45:45 CST 2021, time=2021-11-03, status=1, ipAttribution=)]
    2021-11-05 jingyanzhu715_39486103

    #低分子肝素#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1930277, encodeId=028319302e78a, content=<a href='/topic/show?id=0aac64623a' target=_blank style='color:#2F92EE;'>#EBUS-TBNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6462, encryptionId=0aac64623a, topicName=EBUS-TBNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Sep 11 15:06:45 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906772, encodeId=40531906e72cc, content=<a href='/topic/show?id=6440650062f' target=_blank style='color:#2F92EE;'>#注意事项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65006, encryptionId=6440650062f, topicName=注意事项)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6ac207, createdName=xlwang2691, createdTime=Thu Nov 04 05:06:45 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460860, encodeId=8790146086046, content=<a href='/topic/show?id=b8012e675d7' target=_blank style='color:#2F92EE;'>#停药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27675, encryptionId=b8012e675d7, topicName=停药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c6d6379100, createdName=yinhl1980, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466747, encodeId=9b931466e471e, content=<a href='/topic/show?id=67f3e463637' target=_blank style='color:#2F92EE;'>#禁忌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74636, encryptionId=67f3e463637, topicName=禁忌症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06006859456, createdName=xlxchina, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481464, encodeId=e07d1481464c0, content=<a href='/topic/show?id=cf432615e79' target=_blank style='color:#2F92EE;'>#低分子肝素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26157, encryptionId=cf432615e79, topicName=低分子肝素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=192e7793966, createdName=jingyanzhu715_39486103, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545124, encodeId=7b30154512471, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066636, encodeId=471510666361f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edc65641393, createdName=ms9000001434185440, createdTime=Wed Nov 03 16:45:45 CST 2021, time=2021-11-03, status=1, ipAttribution=)]
    2021-11-05 医者仁心

    #禁忌#

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1930277, encodeId=028319302e78a, content=<a href='/topic/show?id=0aac64623a' target=_blank style='color:#2F92EE;'>#EBUS-TBNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6462, encryptionId=0aac64623a, topicName=EBUS-TBNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sun Sep 11 15:06:45 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1906772, encodeId=40531906e72cc, content=<a href='/topic/show?id=6440650062f' target=_blank style='color:#2F92EE;'>#注意事项#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65006, encryptionId=6440650062f, topicName=注意事项)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6ac207, createdName=xlwang2691, createdTime=Thu Nov 04 05:06:45 CST 2021, time=2021-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460860, encodeId=8790146086046, content=<a href='/topic/show?id=b8012e675d7' target=_blank style='color:#2F92EE;'>#停药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27675, encryptionId=b8012e675d7, topicName=停药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c6d6379100, createdName=yinhl1980, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466747, encodeId=9b931466e471e, content=<a href='/topic/show?id=67f3e463637' target=_blank style='color:#2F92EE;'>#禁忌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74636, encryptionId=67f3e463637, topicName=禁忌症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06006859456, createdName=xlxchina, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481464, encodeId=e07d1481464c0, content=<a href='/topic/show?id=cf432615e79' target=_blank style='color:#2F92EE;'>#低分子肝素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26157, encryptionId=cf432615e79, topicName=低分子肝素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=192e7793966, createdName=jingyanzhu715_39486103, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545124, encodeId=7b30154512471, content=<a href='/topic/show?id=b7abe4635e0' target=_blank style='color:#2F92EE;'>#禁忌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74635, encryptionId=b7abe4635e0, topicName=禁忌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Nov 05 05:06:45 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066636, encodeId=471510666361f, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edc65641393, createdName=ms9000001434185440, createdTime=Wed Nov 03 16:45:45 CST 2021, time=2021-11-03, status=1, ipAttribution=)]
    2021-11-03 ms9000001434185440

    学习

    0

相关资讯

中国中药协会呼吸病药物研究专业委员会在京成立

1月19日， 由中国中药协会主办的“中国中药协会呼吸病药物研究专业委员会成立大会暨首届呼吸病学术研讨会”在北京召开，吸引了来自全国各地的300多名呼吸科中西医临床、药学、医药研究专家、学者和企业代表参会，共同商讨呼吸病药物研究与评价事业的发展。

浙江省肿瘤医院李亚清：教授直播解读：支气管镜下诊疗技术临床应用

⌚ 8月18日晚19:00直播，《支气管镜介入治疗》等11本好书免费领

呼吸科受关注的10篇论文；每一篇都很有启发

做科研、尤其是选题，需要读很多文献；

秋季鼻炎 痛苦如“绝症”! 70岁呼吸科老主任教你一招破解

有一种疾病，我国不同程度的患病人群高达3亿人，相当于每4个人就有一个人在饱受折磨。那就是鼻炎。

呼吸科经典病例推荐——支原体肺炎

由肺炎支原体引起的肺炎，曾称原发性非典型性肺炎，常见呼吸系统传染病，本病呈世界分布，以温带为主。全年均有发生，以秋季为主。呈周期性流行，间隔约4～5年，发病数可较常年高3～5倍。本病多在家庭、军队、学校或集体住宅区内流行，或呈地区性流行。本病起病缓慢，有发热、阵发性刺激性咳嗽，少量黏液性或黏液脓性痰(偶有血痰)。肺部体征多不明显，但易引起肺外多系统受累，也可威胁生命或死亡。好发于儿童或青少年，

呼吸科医生能和病人谈恋爱吗？

前几天，在微信朋友圈中看到一则与本文同名的帖子，觉得很有意思，手痒也想写写这个话题。我看到的那则帖子，从医患关系的角度来陈述医生与病人谈恋爱这个十分罕见的情况。实际上，这个命题本身就不好。只要是真爱，任何人都可以和心心相印的人在天愿作比翼鸟、在地愿做连理枝，硬要往恋人身上套职业的外衣非常不科学。类似的不聪明问题还有：“银行柜台员可以和储户谈恋爱吗？”、“杀猪佬可以和养猪专业户谈恋爱吗？”、“警察可